logo
Select company
Select metric
$ 0Cost of Revenue
VS
Market
76
Sector
55
Industry
29
History
-
$ 0.38Close
$ 0.23 - $ 1.23 52-Week Range
Ticker Information

Ticker

ADIL

Company Name

ADIAL PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ADIAL PHARMACEUTICALS INC - Cost of Revenue Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADIL - COGS Historical data
DateCost of Revenue
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADIAL PHARMACEUTICALS INC's latest trailing twelve months (TTM) COGS stands at $ 0.
  • Over the past 5 years, ADIAL PHARMACEUTICALS INC's average COGS has been $ 0.
  • The median COGS for ADIAL PHARMACEUTICALS INC during this period was $ 0
  • ADIAL PHARMACEUTICALS INC reached its highest COGS over the past 5 years at $ 0.
  • The lowest COGS recorded by ADIAL PHARMACEUTICALS INC in the same timeframe $ 0

Definition of Cost of Revenue

[Income Statement] The cost of revenue is the total amount paid to produce and sell a product or service and can be found in the income statement.

ADIL - Cost of Revenue, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 0

Maximum

Sep 30, 2020

$ 0

Average

$ 0

Median

COGS Benchmark Analysis

The chart above depicts the distribution of COGS for companies in the Total Stock Market. The average COGS of the companies is $ 111.94M with a standard deviation of $ 181.77M.
The following table provides additional summary stats:
COGS in the Market:
filtered constituents2.94K
min$ -168.96M
max$ 758.54M
average$ 111.94M
median$ 13.43M
std$ 181.77M